# GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)

> **NCT01100333** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 2552 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Recombinant human follicle stimulating hormone (r-hFSH)

## Key facts

- **NCT ID:** NCT01100333
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 2552 (ACTUAL)
- **Last updated:** 2014-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100333, "GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01100333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*